DNA microarrays in clinical practice: Past, present, and future

Clinical and Experimental Medicine

Volumn 3, Issue 1, 2003, Pages 1-3

  Sevenet, N ^a   Cussenot, O ^b  

^a HÔPITAL LARIBOISIÈRE   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Gene expression; Microarray; Prediction; Prognosis

Indexed keywords

BIOLOGICAL MARKER;

CLINICAL PRACTICE; DIAGNOSTIC VALUE; DNA MICROARRAY; GENE EXPRESSION; GENOME; HUMAN; MOLECULAR BIOLOGY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TRANSCRIPTION REGULATION;

GENE EXPRESSION; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS;

EID: 0038358258     PISSN: 15918890     EISSN: None     Source Type: Journal    
DOI: 10.1007/s102380300008     Document Type: Review

References (23)

1. Van't Veer LJ, Dai H, Van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, Van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530-536
2. Bertucci F, Nasser V, Granjeaud S, Eisinger F, Adelaide J, Tagett R, Loriod B, Giaconia A, Benziane A, Devilard E, Jacquemier J, Viens P, Nguyen C, Birnbaum D, Houlgatte R (2002) Gene expression profiles of poor-prognosis primary breast cancer correlate with survival. Hum Mol Genet 11:863-872
3. Van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, van der Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347:1999-2009
4. Fodor SP, Read JL, Pirrung MC, Stryer L, Lu AT, Solas D (1991) Light-directed, spatially addressable parallel chemical synthesis. Science 251:767-773
5. Schena M, Shalon D, Davis RW, Brown PO (1995) Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270:467-470
6. Shalon D, Smith SJ, Brown PO (1996) A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization. Genome Res 6:639-645
7. DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M, Chen Y, Su YA, Trent JM (1996) Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet 14:457-460
8. Guo QM (2003) DNA microarray and cancer. Curr Opin Oncol 15:36-43
9. Rubin MA (2001) Use of laser capture microdissection, cDNA microarrays, and tissue microarrays in advancing our understanding of prostate cancer. J Pathol 195:80-86
10. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, Aach J, Ansorge W, Ball CA, Causton HC, Gaasterland T, Glenisson P, Holstege FC, Kim IF, Markowitz V, Matese JC, Parkinson H, Robinson A, Sarkans U, Schulze-Kremer S, Stewart J, Taylor R, Vilo J, Vingron M (2001) Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 29:365-371
11. Warner EE, Dieckgraefe BK (2002) Application of genome-wide gene expression profiling by high-density DNA arrays to the treatment and study of inflammatory bowel disease. Inflamm Bowel Dis 8:140-157
12. Anthony RM, Brown TJ, French GL (2001) DNA array technology and diagnostic microbiology. Expert Rev Mol Diagn 1:30-38
13. Middleton FA, Mirnics K, Pierri JN, Lewis DA, Levitt P (2002) Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J Neurosci 22:2718-2729
14. Tannapfel A, Geissler F, Witzigmann H, Hauss J, Wittekind C (2001) Analysis of liver allograft rejection related genes using cDNA-microarrays in liver allograft specimen. Transplant Proc 33:3283-3284
15. Sarwal M, Chang S, Barry C, Chen X, Alizadeh A, Salvatierra O, Brown P (2001) Genomic analysis of renal allograft dysfunction using cDNA microarrays. Transplant Proc 33:297-298
16. Walker J, Flower D, Rigley K (2002) Microarrays in hematology. Curr Opin Hematol 9:23-29
17. Monni O, Hyman E, Mousses S, Barlund M, Kallioniemi A, Kallioniemi OP (2001) From chromosomal alterations to target genes for therapy: integrating cytogenetic and functional genomic views of the breast cancer genome. Semin Cancer Biol 11:395-401
18. Belbin TJ, Singh B, Barber I, Socci N, Wenig B, Smith R, Prystowsky MB, Childs G (2002) Molecular classification of head and neck squamous cell carcinoma using cDNA microarrays. Cancer Res 62:1184-1190
19. Raguenez G, Douc-Rasy S, Blanc E, Goldschneider D, Barrois M, Valteau-Couanet D, Benard J (2001) A functional gene map is required to adapt therapy of metastatic neuroblastoma. Bull Cancer 88:295-304
20. Cai WW, Mao JH, Chow CW, Damani S, Balmain A, Bradley A (2002) Genome-wide detection of chromosomal imbalances in tumors using BAC microarrays. Nat Biotechnol 20:393-396
21. Ameen M, Smith CH, Barker JN (2002) Pharmacogenetics in clinical dermatology. Br J Dermatol 146:2-6
22. Li X, Gu W, Mohan S, Baylink DJ (2002) DNA microarrays: their use and misuse. Microcirculation 9:13-22
23. Katsuma S, Tsujimoto G (2001) Genome medicine promised by microarray technology. Expert Rev Mol Diagn 1:377-382